The Family Pet Podcast
Ep. 73 - New treatments for arthritic pets - w/ Dr. Tamara Grubb
Ep. 73 - New treatments for arthritic pets - Show Notes
Our pets can suffer from arthritis, just like their human owners. For years, the only treatment has been non-steroidal anti-inflammatory drugs (NSAIDS.) However, two drugs have recently been approved by the FDA for our pets.
Dr. Tamara Grubb returns to the podcast to explain how these new drugs, utilizing the science of monoclonal antibodies, are revolutionizing the treatment of osteoarthritis for our pets.
Here are links to information we talked about today:
- Listen to Dr. Tamara Grubb’s first visit to The Family Pet Podcast in Episode 35
- This explainer from the Cleveland Clinic explains monoclonal antibodies in human medicine and is a good insight into what the future might hold for pet medicine
- Dog owners can learn about Librela
- Cat owners can learn about Solensia
Zoetis announced the U.S. commercial launch of Librela (bedinvetmab injection), which the company says is the first and only anti-NGF monoclonal antibody treatment to control canine osteoarthritis pain. The product in May received approval from the FDA.
Got a question for Michael and Stephen? Run across something interesting you want to share with the show? Do you have a topic idea for a future episode? Send it to us at thefamilypetpodcast@gmail.com.
Ep. 73 - New treatments for arthritic pets - Show Notes
Our pets can suffer from arthritis, just like their human owners. For years, the only treatment has been non-steroidal anti-inflammatory drugs (NSAIDS.) However, two drugs have recently been approved by the FDA for our pets.
Dr. Tamara Grubb returns to the podcast to explain how these new drugs, utilizing the science of monoclonal antibodies, are revolutionizing the treatment of osteoarthritis for our pets.
Here are links to information we talked about today:
- Listen to Dr. Tamara Grubb’s first visit to The Family Pet Podcast in Episode 35
- This explainer from the Cleveland Clinic explains monoclonal antibodies in human medicine and is a good insight into what the future might hold for pet medicine
- Dog owners can learn about Librela
- Cat owners can learn about Solensia
Zoetis announced the U.S. commercial launch of Librela (bedinvetmab injection), which the company says is the first and only anti-NGF monoclonal antibody treatment to control canine osteoarthritis pain. The product in May received approval from the FDA.
Got a question for Michael and Stephen? Run across something interesting you want to share with the show? Do you have a topic idea for a future episode? Send it to us at thefamilypetpodcast@gmail.com.